[go: up one dir, main page]

Jenei et al., 2011 - Google Patents

Packing of transmembrane domain 2 of carnitine palmitoyltransferase‐1A affects oligomerization and malonyl‐CoA sensitivity of the mitochondrial outer membrane …

Jenei et al., 2011

View PDF @Full View
Document ID
8319808729988587057
Author
Jenei Z
Warren G
Hasan M
Zammit V
Dixon A
Publication year
Publication venue
The FASEB Journal

External Links

Snippet

The purpose of this study was to investigate the sequence‐dependence of oligomerization of transmembrane domain 2 (TM2) of rat carnitine palmitoyltransferase 1A (rCPT1A), to elucidate the role of this domain in the function of the full‐length enzyme. Oligomerization of …
Continue reading at faseb.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates

Similar Documents

Publication Publication Date Title
Baranova et al. Three-dimensional structure of α-crystallin domain dimers of human small heat shock proteins HSPB1 and HSPB6
Kang et al. Crystallography and mutagenesis point to an essential role for the N-terminus of human mitochondrial ClpP
Brasch et al. Structure and binding mechanism of vascular endothelial cadherin: a divergent classical cadherin
Correale et al. Molecular organization of the cullin E3 ligase adaptor KCTD11
Agou et al. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains
Bowman et al. Oligomerization and higher‐order assembly contribute to sub‐cellular localization of a bacterial scaffold
Okamoto et al. Multiple distinct coiled-coils are involved in dynamin self-assembly
Kuwabara et al. Structure of a BAG6 (Bcl-2-associated athanogene 6)-Ubl4a (ubiquitin-like protein 4a) complex reveals a novel binding interface that functions in tail-anchored protein biogenesis
Lanfermeijer et al. Kinetics and consequences of binding of nona-and dodecapeptides to the oligopeptide binding protein (OppA) of Lactococcus lactis
Gutierrez-Ford et al. Characterization of tescalcin, a novel EF-hand protein with a single Ca2+-binding site: metal-binding properties, localization in tissues and cells, and effect on calcineurin
Kostyukova et al. Structural requirements of tropomodulin for tropomyosin binding and actin filament capping
Reina et al. Deletion of β-strands 9 and 10 converts VDAC1 voltage-dependence in an asymmetrical process
Ebie et al. Dimerization of the erythropoietin receptor transmembrane domain in micelles
Hisamitsu et al. Dimeric interaction between the cytoplasmic domains of the Na+/H+ exchanger NHE1 revealed by symmetrical intermolecular cross-linking and selective co-immunoprecipitation
Cerna et al. The structure of Sif2p, a WD repeat protein functioning in the SET3 corepressor complex
KR20190104409A (en) Lipocalin muteins with binding affinity for LAG-3
Jenei et al. Packing of transmembrane domain 2 of carnitine palmitoyltransferase‐1A affects oligomerization and malonyl‐CoA sensitivity of the mitochondrial outer membrane protein
Sung et al. Tropomyosin isoform 5b is expressed in human erythrocytes: implications of tropomodulin-TM5 or tropomodulin-TM5b complexes in the protofilament and hexagonal organization of membrane skeletons
Francis et al. The single C‐terminal helix of human phospholipid scramblase 1 is required for membrane insertion and scrambling activity
Montioli et al. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine: glyoxylate aminotransferase and chaperoning activity of pyridoxine
Regis et al. On the difference in stability between horse and sperm whale myoglobins
Pylypenko et al. Farnesylation of the SNARE protein Ykt6 increases its stability and helical folding
Freye-Minks et al. Structural and dynamic changes in human annexin VI induced by a phosphorylation-mimicking mutation, T356D
Fould et al. Structural and functional characterization of the recombinant human mitochondrial trifunctional protein
He et al. Self-association of poly (A)-specific ribonuclease (PARN) triggered by the R3H domain